ARS Pharmaceuticals (SPRY) Property, Plant & Equipment (Net) (2020 - 2026)

ARS Pharmaceuticals (SPRY) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	642,333.36
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	5.32 Mn
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	31.48 Mn
10	ARS Pharmaceuticals	595.78 Mn	394.81 Mn	-	2.29 Mn

Download Data